Jinko aims to offer a personalized and multidisciplinary care pathway to people affected by cancer. Thanks to a holistic and multidisciplinary approach, Jinko offers, through a proprietary platform, care in dietetics, psychology, adapted physical activity, socio-aesthetics and osteopathy.
Jinko has raised €2.0M across 1 funding round from 4 investors, most recently a Seed round in Sep 2024. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-17 | Seed | €2.0M |
| 360 Capital,Alliance For Impact Ventures,Business Angels,Ventech's impact fund |
| View deal → |
